View in EDS HTML Full Text PDF Full Text

Regulatory-required post-marketing database studies in Japan could be leveraged to assess important potential risks as well as identified risks.

Saved in:
Bibliographic Details
Title: Regulatory-required post-marketing database studies in Japan could be leveraged to assess important potential risks as well as identified risks.
Authors: Yamazaki H; Global Epidemiology, Johnson & Johnson, Tokyo, Japan., Nakajo K; Global Epidemiology, Johnson & Johnson, Tokyo, Japan., Hirose N; Global Epidemiology, Johnson & Johnson, Tokyo, Japan., Yan L; Global Epidemiology, Johnson & Johnson, Beijing, China., Lee SY; Global Epidemiology, Johnson & Johnson, Seoul, Republic of Korea., Zhang Y; Global Epidemiology, Johnson & Johnson, Beijing, China., Qiu H; Global Epidemiology, Johnson & Johnson, Titusville, NJ, United States., Ishiguro C; Laboratory of Epidemiology Section, Department of Data Science, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan.
Source: Frontiers in pharmacology [Front Pharmacol] 2025 Jul 21; Vol. 16, pp. 1565314. Date of Electronic Publication: 2025 Jul 21 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40761405
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Regulatory-required post-marketing database studies in Japan could be leveraged to assess important potential risks as well as identified risks.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yamazaki+H%22">Yamazaki H</searchLink>; Global Epidemiology, Johnson & Johnson, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nakajo+K%22">Nakajo K</searchLink>; Global Epidemiology, Johnson & Johnson, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hirose+N%22">Hirose N</searchLink>; Global Epidemiology, Johnson & Johnson, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yan+L%22">Yan L</searchLink>; Global Epidemiology, Johnson & Johnson, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Lee+SY%22">Lee SY</searchLink>; Global Epidemiology, Johnson & Johnson, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Global Epidemiology, Johnson & Johnson, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Qiu+H%22">Qiu H</searchLink>; Global Epidemiology, Johnson & Johnson, Titusville, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Ishiguro+C%22">Ishiguro C</searchLink>; Laboratory of Epidemiology Section, Department of Data Science, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2025 Jul 21; Vol. 16, pp. 1565314. <i>Date of Electronic Publication: </i>2025 Jul 21 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40761405
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2025.1565314
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1565314
    Titles:
      – TitleFull: Regulatory-required post-marketing database studies in Japan could be leveraged to assess important potential risks as well as identified risks.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yamazaki H
      – PersonEntity:
          Name:
            NameFull: Nakajo K
      – PersonEntity:
          Name:
            NameFull: Hirose N
      – PersonEntity:
          Name:
            NameFull: Yan L
      – PersonEntity:
          Name:
            NameFull: Lee SY
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Qiu H
      – PersonEntity:
          Name:
            NameFull: Ishiguro C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 07
              Text: 2025 Jul 21
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1